Stay updated on Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page.

Latest updates to the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision stamp was updated from v3.6.4 to v3.6.5, reflecting a minor update to the page's versioning. This update does not alter the study details, eligibility criteria, or other content on the page.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision metadata was updated from v3.6.3 to v3.6.4, indicating a minor update to the page version. The change does not alter study content or function.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a minor update to the page.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now displays the revision tag Revision: v3.6.2, replacing Revision: v3.6.0. This update concerns the page's versioning metadata rather than the study content.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded a recruitment status note ('No longer looking for participants') to clarify that enrollment is closed. The page also adds help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting along with revision metadata to v3.6.0.SummaryDifference0.4%

- Check65 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a small page maintenance update.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS-986253 in Prostate Cancer Clinical Trial page.